Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSavills Regulatory News (SVS)

Share Price Information for Savills (SVS)

Share Price is delayed by 15 minutes
Get Live Data
808.00    -10.00 (-1.22%)
Bid:
811.00
Ask:
813.00
Spread: 2.00 (0.247%)
Market Cap: £1.12b
SVS Live PriceLast checked at - London Stock Exchange

Intraday Savills Share Chart

Interim Management Statement

8 May 2013 11:00

RNS Number : 2291E
Savills PLC
08 May 2013
 



 

8 May 2013

SAVILLS PLC

("Savills" or "the Company")

 

AGM Statement and Interim Management Statement

 

Savills plc, the international real estate advisor, is today holding its Annual General Meeting (AGM) at 12 noon, 20 Grosvenor Hill, Berkeley Square, London W1K 3HQ and provides the following Interim Management Statement (IMS) for the period to 8 May 2013.

 

During the first four months of the year Savills has traded as anticipated with strong growth in Asia, a robust performance from the newly combined UK businesses and a continued reduction in losses in Continental Europe. Our US business has also shown improved performance in comparison with the same period last year and Cordea Savills, the Group's investment management business, has traded in line with our expectations. As previously indicated, we expect that our trading result to date will result in a stronger first half performance than in 2012 with the full year outlook in line with our expectations.

 

To date trading across the Asia Pacific region has remained strong with substantial improvements year on year. Looking forward, as anticipated, the residential markets in Hong Kong are being significantly affected by the latest round of Government control measures implemented in March with volumes falling by circa 30%. The doubling of stamp duty on commercial transactions in Hong Kong has also reduced the aggregate value of transactions since its implementation. We anticipate that improvements in trading in other parts of the region, particularly Australia and Japan will help to mitigate the financial impact of reduced transactional volumes in Hong Kong.

 

London's attractions as an investment location remain firmly established and indeed potentially enhanced by fiscal and other control measures implemented in other markets. In the UK commercial market Savills has continued to maintain a significant share of the Prime Central London investment and leasing markets, although the shortage of supply of investment stock has become apparent. The increasing interest of overseas investors in Prime Central London assets has resulted in more domestic investors looking to opportunities in the UK's principal regional cities. Whilst it is still too early to be definitive, if this trend continues, we expect to see some improvements in our regional UK business through the coming period.

 

The Prime Residential market in central London has continued to perform strongly with year on year increases in both volume and value. Outside London, although it is early in the selling season, we have seen some improvement in the volume of activity in the traditionally stronger regional markets evidenced by improved volumes of new stock, applicants and viewings.

 

Globally, our Consultancy business has experienced double digit revenue growth with particular strengths in Planning and Development consultancy. The Property Management business has continued to deliver a solid increase in revenue.

 

Following a year of strategic changes and operational developments undertaken in 2012, Cordea Savills is now focused on further growth initiatives in Europe and Asia.

 

 

For further information, contact:

 

Savills 020 7409 8934

Jeremy Helsby, Group Chief Executive

Simon Shaw, Group Chief Financial Officer

 

Tulchan Communications 020 7353 4200

Peter Hewer/Martha Walsh

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
IMSEANSPEANDEEF
Date   Source Headline
1st Oct 202511:00 amRNSTotal Voting Rights
29th Sep 202512:09 pmRNSDirector Declaration
25th Sep 20257:00 amRNSDirectorship Change
11th Sep 202512:38 pmRNSDirector/PDMR Shareholding
5th Sep 20252:00 pmRNSAdditional Listing
14th Aug 20257:00 amRNSHalf-year Report
12th Aug 20252:39 pmRNSDirector/PDMR Shareholding
1st Aug 20253:41 pmRNSHolding(s) in Company
21st Jul 20252:03 pmRNSBlock listing Interim Review
16th Jul 20251:44 pmRNSHolding(s) in Company
15th Jul 20254:20 pmRNSHolding(s) in Company
14th Jul 20251:14 pmRNSHolding(s) in Company
14th Jul 202510:18 amRNSDirector/PDMR Shareholding
1st Jul 20257:00 amRNSTotal Voting Rights
30th Jun 20255:20 pmRNSDirector/PDMR Shareholding
23rd Jun 20252:45 pmRNSHolding(s) in Company
20th Jun 20254:00 pmRNSAdditional Listing
12th Jun 20258:15 amRNSDirector/PDMR Shareholding
12th Jun 20258:10 amRNSDirector/PDMR Shareholding
10th Jun 20255:57 pmRNSDirector/PDMR Shareholding
4th Jun 202512:12 pmRNSHolding(s) in Company
2nd Jun 20253:05 pmRNSHolding(s) in Company
2nd Jun 20258:58 amRNSHolding(s) in Company
22nd May 20255:31 pmRNSHolding(s) in Company
15th May 20254:06 pmRNSHolding(s) in Company
14th May 20252:38 pmRNSResult of AGM
14th May 20257:00 amRNSAGM Statement
13th May 20254:01 pmRNSDirector/PDMR Shareholding
29th Apr 20257:00 amRNSSavills Announces Succession Plan
7th Apr 20254:18 pmRNSAnnual Report and AGM Notice
1st Apr 202511:00 amRNSTotal Voting Rights
24th Mar 20252:18 pmRNSHolding(s) in Company
21st Mar 20253:00 pmRNSAdditional Listing
20th Mar 20259:21 amRNSDirector/PDMR Shareholding
18th Mar 20252:27 pmRNSHolding(s) in Company
13th Mar 20257:00 amRNSFinal Results
12th Mar 202511:00 amRNSDirector/PDMR Shareholding
17th Feb 20254:43 pmRNSBlock listing Interim Review
12th Feb 202511:10 amRNSDirector/PDMR Shareholding
11th Feb 20252:32 pmRNSHolding(s) in Company
7th Feb 20253:51 pmRNSHolding(s) in Company
3rd Feb 202511:00 amRNSTotal Voting Rights
29th Jan 20252:28 pmRNSHolding(s) in Company
28th Jan 20253:47 pmRNSHolding(s) in Company
22nd Jan 202511:47 amRNSBlock listing Interim Review
16th Jan 20257:00 amRNSYear End Trading Update
13th Jan 20252:35 pmRNSDirector/PDMR Shareholding
2nd Jan 20253:00 pmRNSTotal Voting Rights
16th Dec 20244:03 pmRNSHolding(s) in Company
12th Dec 202411:00 amRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.